ZTS Q1 2022 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$54B

Q1 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2.0B+6.1% YoY

Gross Profit

$1.4B69.3% margin

Operating Income

$789M39.7% margin

Net Income

$595M30.0% margin

EPS (Diluted)

$1.26

QoQ Revenue Growth

+1.0%

Cash Flow

Operating Cash Flow

$309M

Free Cash Flow

$194M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$13.9B

Total Liabilities

$9.2B

Stockholders' Equity

$4.7B

Cash & Equivalents

$3.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.0B	$1.9B	+6.1%
Gross Profit	$1.4B	$1.3B	+7.3%
Operating Income	$789M	$755M	+4.5%
Net Income	$595M	$559M	+6.4%

Revenue Segments

Dogs and Cats

$1.2B62%

Cattle

$364M19%

Swine

$154M8%

Poultry

$124M6%

Horses

$64M3%

Fish

$44M2%

Geographic Segments

United States Segment

$1.0B52%

International Segment

$948M48%